Free Trial

Teladoc Health (TDOC) Earnings Date, Estimates & Call Transcripts

Teladoc Health logo
$7.14 +0.09 (+1.20%)
Closing price 03:59 PM Eastern
Extended Trading
$7.18 +0.04 (+0.56%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Teladoc Health Earnings Summary

Latest Q4
Earnings Date
Feb. 26Estimated
Consensus EPS
(Feb. 26)
-$0.21
Actual EPS
(Feb. 26)
-$0.28 Missed By -$0.07
Actual Revenue
(Feb. 26)
$640.49M

Teladoc Health released Q4 2024 earnings on February 26, 2025, reporting an EPS of -$0.28, which missed the consensus estimate of -$0.21 by $0.07. Quarterly revenue was reported to be $640.49 million, above analysts' expectations of $639.44 million. With a trailing EPS of -$5.92, Teladoc Health's earnings are expected to grow next year, from ($1.16) to ($0.98) per share.

Q4 2024 Earnings Resources

Get Teladoc Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teladoc Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TDOC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TDOC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Teladoc Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20253-$0.40-$0.31-$0.34$633.0 M - 0.400 - - 0.150$608.0 M - $629.0 M
Q2 20253-$0.28-$0.20-$0.25$625.3 M - 0.400 - - 0.200$614.0 M - $633.0 M
Q3 20253-$0.24-$0.18-$0.21
Q4 20253-$0.26-$0.18-$0.21
FY 2025 12 -$1.18 -$0.87 -$1.02
Q1 20262-$0.37-$0.32-$0.35
Q2 20262-$0.21-$0.18-$0.20
Q3 20262-$0.21-$0.17-$0.19
Q4 20262-$0.17-$0.11-$0.14

Teladoc Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/26/2025Q4 2024-$0.21-$0.28 -$0.07-$0.28$639.44M$640.49M
10/30/2024Q3 2024-$0.29-$0.19+$0.10-$0.19$630.50M$640.51M
7/31/2024Q2 2024-$0.36-$0.28+$0.08$4.36$649.34M$642.44M
4/25/2024Q1 2024-$0.47-$0.49 -$0.02-$0.49$637.31M$646.13M
2/20/2024Q4 2023-$0.22-$0.17+$0.05-$0.17$670.79M$660.50M
10/24/2023Q3 2023-$0.37-$0.35+$0.02-$0.35$662.71M$660.24M
7/25/2023Q2 2023-$0.44-$0.40+$0.04-$0.40$649.20M$652.41M

Teladoc Health Earnings - Frequently Asked Questions

Teladoc Health (NYSE:TDOC) last announced its quarterly earning data on Wednesday, February 26, 2025. Learn more on TDOC's earnings history.

Teladoc Health issued an update on its second quarter 2025 earnings guidance on Wednesday, April, 30th. The company provided earnings per share guidance of -0.400--0.200 for the period, compared to the consensus EPS estimate of -0.230. The company issued revenue guidance of $614.0 million-$633.0 million, compared to the consensus revenue estimate of $625.3 million.

In the previous quarter, Teladoc Health (NYSE:TDOC) missed the analysts' consensus estimate of ($0.21) by $0.07 with a reported earnings per share (EPS) of ($0.28). Learn more on analysts' earnings estimate vs. TDOC's actual earnings.

The conference call for Teladoc Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Teladoc Health's latest earnings report can be read online.
Read Transcript

Teladoc Health's earnings report can be found in their filing with the SEC.
View SEC filing

Teladoc Health (NYSE:TDOC) has a recorded annual revenue of $2.55 billion.

Teladoc Health (NYSE:TDOC) has a recorded net income of -$220.37 million. TDOC has generated -$5.92 earnings per share over the last four quarters.

Teladoc Health's earnings are expected to grow from ($1.16) per share to ($0.98) per share in the next year.

More Earnings Resources from MarketBeat



This page (NYSE:TDOC) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners